| QUOTE |
| While the FDA approved the device for the most difficult-to-treat depression patients, getting it paid for has been difficult. The contractor that makes decisions on what the federal Medicare program will cover in Florida, First Coast Service Options, recently decided the clinical evidence isn't conclusive enough to justify coverage. "It is our hope that trial studies will be made available to patients, and sufficient positive data ... will allow FCSO to cover this service," the Jacksonville-based company said when its decision was announced. |